fluoxetine has been researched along with deamino arginine vasopressin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Abdelhalim, A; El-Kenawy, MR; Hashem, A; Helmy, TE; Hussiny, M; Soltan, MA | 1 |
1 review(s) available for fluoxetine and deamino arginine vasopressin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for fluoxetine and deamino arginine vasopressin
| Article | Year |
|---|---|
The Safety and Efficacy of Fluoxetine for the Treatment of Refractory Primary Monosymptomatic Nocturnal Enuresis in Children: A Randomized Placebo-Controlled Trial.
Topics: Adolescent; Child; Cholinergic Antagonists; Deamino Arginine Vasopressin; Fluoxetine; Humans; Nocturnal Enuresis; Selective Serotonin Reuptake Inhibitors | 2022 |